Phase I trial of a PSMA DNA vaccine for patients(pts) with good risk renal cell carcinoma(RCC)

16073 Background: Prostate Specific Membrane Antigen (PSMA) is a self antigen first identified as a marker for epithelial cells in the prostate but is expressed on the vascular endothelium of metas...